<DOC>
	<DOCNO>NCT01062269</DOCNO>
	<brief_summary>The purpose research study ( 1 ) rate taste , texture , appearance , mixability 2 different dos orange flavor cholestyramine compare orange flavor Tang , ( 2 ) rank importance taste , texture , appearance , mixability rating cholestyramine Tang determine accuracy usefulness taste test questionnaire .</brief_summary>
	<brief_title>A Single Research Site Bile Acid Sequestrant Acceptability ( BASA ) Scale Pilot Validation Study</brief_title>
	<detailed_description>The primary objective study evaluate patient acceptability 2 dose orange-flavored generic Questran ( cholestyramine ) versus orange-flavored Tang Drink Mix ( commercial powder orange drink without cholestyramine ) via 2 BASA scale . A second objective ass 2 different version BASA scale . One version unweighted score base upon aggregate score acceptability component . A second version weight base upon subjectively-reported importance acceptability component . The one main study objective focus determine version BASA scale best differentiate patient acceptability bile acid sequestrant ( cholestyramine ) versus placebo control powder ( contain bile acid sequestrant ) thereby determine BASA scale best validated instrument future study assess compare patient acceptability bile acid sequestrants .</detailed_description>
	<mesh_term>Cholestyramine Resin</mesh_term>
	<mesh_term>Bile Acids Salts</mesh_term>
	<criteria>Subjects generally healthy volunteer eligible inclusion meet follow inclusion criterion Screening Period : Men woman 1870 year age In general good health . Subjects capable give informed consent , appropriate , acceptable surrogate capable give consent subject 's behalf . Subjects willing readily able contact poststudy safety phone call assessments one seven day single study visit . Prior intolerance bile acid sequestrants Women either pregnant , practice form birth control . Prior gastrointestinal surgery History ongoing gastrointestinal symptom ( indigestion , constipation , diarrhea ) History bowel obstruction , malabsorption , irritable bowel syndrome History esophageal disease Current past history gall bladder disease Subjects enrol another experimental ( interventional ) protocol within past 30 day prior visit 1 . Diagnosis diabetes mellitus Known history triglyceride level &gt; 300 mg/dl . History alcohol drug abuse within 1 year study entry Alcohol intake exceed 2 unit alcohol drink per day Blood donation within 8 week study anticipation blood donation study . Exposure bile acid sequestrants ( colesevelam HCl , cholestyramine , colestipol within 30 visit 1 ) . Any situation Investigator make judgment participation study would best interest study participant , best interest provide reliable study data .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Bile acid sequestrant</keyword>
	<keyword>Resin</keyword>
	<keyword>Cholesterol</keyword>
	<keyword>Diabetes mellitus</keyword>
	<keyword>Lipids</keyword>
	<keyword>Glucose</keyword>
	<keyword>Bile Acid Sequestrant Acceptability Scale ( BASA ) validation study</keyword>
</DOC>